Transforming Care in C3G and IC-MPGN: Advancing Diagnosis, Disease Monitoring & Targeted Complement Therapy Across the Patient Journey

Join our faculty to review best practices for managing pediatric and adult patients with complement-mediated kidney diseases such as C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN). Strengthen your diagnostic approach and gain practical guidance on the use of recently approved complement inhibitor therapies in these rare diseases.